References
- Yazdi K, Fuchs-Leitner I, Rosenleitner J, Gerstgrasser NW. Impact of the COVID-19 pandemic on patients with alcohol use disorder and associated risk factors for relapse. Front Psychiatry. 2020;11:620612.
- Kim JU, Majid A, Judge R, Crook P, Nathwani R, Selvapatt N, et al. Effect of COVID-19 lockdown on alcohol consumption in patients with pre-existing alcohol use disorder. Lancet Gastroenterol Hepatol. 2020;5(10):886–7. doi:https://doi.org/10.1016/S2468-1253(20)30251-X.
- CARE Checklist [Internet]. CARE Case Report Guidelines. [cited 2021 Apr 9]. Available from: https://www.care-statement.org/checklist.
- Lande RG, Marin B. A comparison of two alcohol biomarkers in clinical practice: Ethyl glucuronide versus ethyl sulfate. J Addict Dis. 2013;32(3):288–92. doi:https://doi.org/10.1080/10550887.2013.824332.
- MacLean RR, Valentine GW, Jatlow PI, Sofuoglu M. Inhalation of alcohol vapor: measurement and implications. Alcohol Clin Exp Res. 2017;41(2):238–50. doi:https://doi.org/10.1111/acer.13291.
- Funk D, Coen K, Tamadon S, Lê AD. Effect of chronic alcohol vapor exposure on reinstatement of alcohol seeking induced by U50,488. Neuropharmacology. 2019;148:210–9. doi:https://doi.org/10.1016/j.neuropharm.2019.01.017.
- Brewer C, Streel E. Is alcohol in hand sanitizers absorbed through the skin or lungs? Implications for disulfiram treatment. Alcohol Alcohol. 2020;55(4):354–6. doi:https://doi.org/10.1093/alcalc/agaa045.